Company Filing History:
Years Active: 2013
Title: The Innovations of Benjamin Stanton
Introduction
Benjamin Stanton is an accomplished inventor based in Menlo Park, CA (US). He is known for his significant contributions to the field of biomedical research, particularly in the development of small molecule inhibitors targeting the Sonic Hedgehog signaling pathway. His work has implications for treating various proliferative diseases and developmental disorders.
Latest Patents
Stanton holds a patent for "Sonic hedgehog modulators." This invention relates to macrocyclic small molecule inhibitors of the Sonic Hedgehog signaling pathway, along with their syntheses and intermediates. These modulators are particularly useful in treating proliferative diseases such as basal cell carcinoma, Gorlin syndrome, medulloblastoma, and pancreatic cancer. Additionally, they have applications in pulmonary diseases like interstitial pneumonitis and interstitial pulmonary fibrosis, as well as developmental disorders such as phocomelia and cyclopia. The patent highlights novel non-natural macrocycles that inhibit Sonic Hedgehog induced-protein transcription.
Career Highlights
Throughout his career, Benjamin Stanton has worked with prestigious institutions, including Harvard College and the Massachusetts Institute of Technology. His research has contributed to advancements in understanding and manipulating the Sonic Hedgehog signaling pathway, which is crucial for various biological processes.
Collaborations
Stanton has collaborated with notable colleagues, including Lee F. Peng and Julia Lamenzo. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the biomedical field.
Conclusion
Benjamin Stanton's work exemplifies the intersection of innovation and practical application in medicine. His patent on Sonic hedgehog modulators showcases his commitment to addressing critical health challenges through scientific research. His contributions continue to influence the landscape of biomedical advancements.